{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Famindr.com%2Fepisodes%2F339-treatments-targeting-neuroprotection-in-alzheimers-disease-XTJVDv_6","width":444,"version":"1.0","type":"rich","title":"339 - Treatments Targeting Neuroprotection in Alzheimer's Disease","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/9a8ef428-72db-47cb-a5cb-a6a258a13785/9faa4765-4452-414b-bd2c-68e86e0a2fb2/339-d4a-text.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/62d65934-7e4c-4b2b-ba40-df2a1ba486a5\" height=\"200\" width=\"100%\" title=\"339 - Treatments Targeting Neuroprotection in Alzheimer&apos;s Disease\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Another series of AMiNDR kicks off with this episode. Anusha takes you through 7 papers published in January 2024 targeting neuroprotection in AD. If you'd like to hear about potential compounds that could reduce neurodegeneration in Alzheimer's disease, this is the episode for you.\n\nTesting for neuroprotection in cell lines (2:57)\nTesting for neuroprotection using in vivo AD models (11:47)"}